Glucotrack completes merger with Lokahi Therapeutics; issues preferred stock and raises bridge financing
Glucotrack, Inc. completed its merger with Lokahi Therapeutics, Inc. on July 14, 2026, with Lokahi becoming a wholly owned subsidiary.
$4.45M$50Mequity90%equity